Skip to main content
. 2021 Aug 18;52(11):3430–3439. doi: 10.1161/STROKEAHA.121.034378

Figure 2.

Figure 2.

Kaplan-Meier analysis of outcomes in the aspirin group. The Kaplan-Meier curves for time to the first event of the primary efficacy outcome, defined as ischemic stroke (A), and to the safety outcome of severe or life-threatening bleeding (B), are shown. HR indicates hazard ratio.